ACADIA Pharmaceuticals Inc at Stifel Virtual Healthcare Conference Transcript
Great. Thanks, everyone, for joining. Happy to be hosting this panel with Steve Davis, CEO of ACADIA Pharmaceuticals; and Elena Ridloff, Chief Financial Officer. We're going to keep it mostly conversational, but Steve, I think you wanted to make some prepared remarks and give a more high level update, and then we can get into Q&A. So thank you, again, and please take it away.
Great. Thanks much, Paul. Yes, just to level set a little bit before we get started with the Q&A. And by the way, very much appreciate being able to present at your conference today. I do need to start with just a brief reminder that the business of pharmaceutical development and commercialization has certain inherent risks. So please see a copy of our most recent SEC filings for a description of how these risks relate to our business.
I'd like to briefly highlight our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
